Report
Experimental compound reportedly reduced four MASH hallmarks in preclinical models
Medical Xpress reports reductions in liver fat, inflammation, injury and scarring, but says it is unclear whether weight loss explains some of the benefits.
TLDR
Medical Xpress reports that an experimental compound reduced four hallmarks of MASH—liver fat, inflammation, injury and scarring—in preclinical models. Whether weight loss explains some of the benefits remains unclear.
Combined views
1.3K
2 Sources, first seen 2h ago
1 likes